"We need to trust women."
BETH MOLE
5/10/2023
A panel of independent medical experts for the Food and Drug Administration voted unanimously on Wednesday in favor of allowing the hormonal birth control pill Opill (norgestrel) to be sold over the counter rather than by prescription.
The 17-0 vote by the panel came after a two-day meeting in which the experts reviewed data and analyses from the pill's maker, Laboratoire HRA Pharma, and FDA scientists, as well as heard public comments on the potential switch.